Skip to main content
Pulike Biological Engineering,Inc. logo

Pulike Biological Engineering,Inc. — Investor Relations & Filings

Ticker · 603566 ISIN · CNE1000025N0 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,080 across all filing types
Latest filing 2016-04-08 Capital/Financing Update
Country CN China
Listing Shanghai Stock Exchange 603566

About Pulike Biological Engineering,Inc.

http://en.pulike.com.cn/

Pulike Biological Engineering, Inc. specializes in the research, development, and production of veterinary biological products and pharmaceutical preparations. The company focuses on animal disease prevention through the manufacture of high-end vaccines, diagnostic reagents, and veterinary medicines. Its product range primarily serves the swine and poultry sectors, featuring advanced biologicals such as genetically engineered vaccines and synthetic peptide products. Pulike maintains a strong emphasis on technological innovation, utilizing national-level research platforms to develop solutions for complex animal health challenges. The company’s core activities encompass the entire value chain from basic biotechnology research to the commercialization of veterinary health solutions, aiming to improve livestock productivity and biosecurity.

Recent filings

Filing Released Lang Actions
关于公司董事会审议高送转的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from the board of directors of 普莱柯生物工程股份有限公司 regarding the board's approval of a proposal for a high dividend payout and stock bonus (capital reserve to share capital conversion) based on the 2015 fiscal year results. It details the dividend amount, stock split ratio, voting results of the board, shareholder proposals, and risk warnings. The document is not a full annual report or financial statement but an official announcement of the board's resolution and related shareholder information. It does not contain comprehensive financial data or detailed management discussion but focuses on the board's decision and shareholder voting intentions related to profit distribution and capital increase. This fits the category of a Capital/Financing Update (CAP) because it concerns changes in capital structure and dividend distribution plans approved by the board and proposed to shareholders.
2016-04-08 Chinese
公司章程（2016修订）
Governance Information Classification · 100% confidence The document is titled as the "公司章程" which translates to "Articles of Association" or "Company Bylaws". It contains detailed provisions about the company's organization, shareholder rights, board of directors, management, financial accounting, profit distribution, and other governance matters. It is a legal and governance document that sets out the internal rules and structure of the company. There is no indication that this is an annual report, financial statement, earnings release, or any other financial or regulatory filing. It is not a report publication announcement or a short notice. The content aligns with governance information about the company's internal rules and board structure. Therefore, the appropriate classification is Governance Information (CGR). The document length is substantial (15,000 characters), supporting that it is a full governance document rather than a brief announcement or notice.
2016-04-08 Chinese
募集资金年度存放与使用情况鉴证报告
Regulatory Filings
2016-04-08 Chinese
平安证券有限责任公司关于普莱柯生物工程股份有限公司2015年募集资金存放与实际使用情况的核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed verification opinion from Ping An Securities regarding the storage and actual use of funds raised by Pulike Bioengineering Co., Ltd. in 2015. It includes specifics on the amount raised, usage, management, investment projects, and compliance with regulatory requirements. The document references regulatory rules related to fundraising and includes audit opinions and detailed financial data on the use of raised funds. This type of document is a standalone audit or verification report on fundraising activities, not a full annual or interim report, nor an announcement or presentation. Therefore, it fits the category of Audit Report / Information (AR). The document length (6110 characters) and content confirm it is a substantive report, not just an announcement or certification. FY 2015
2016-04-08 Chinese
关于公司2015年度募集资金存放与实际使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is a detailed report on the company's 2015 annual fundraising (募集资金) storage and actual usage situation. It includes specifics on the amount raised, usage of funds, management of funds, investment projects funded by the raised capital, cash management of idle funds, and compliance with regulatory requirements. It also contains auditor and sponsor institution opinions on the fundraising usage. The document is not a general annual report or earnings release but a specialized report focused on the use of raised capital. This matches the description of a Capital/Financing Update (CAP) filing, which covers updates on company fundraising and capital structure changes. The document length (6335 characters) and detailed financial data support this classification rather than a simple announcement or regulatory filing. Therefore, the filing type is CAP with high confidence.
2016-04-08 Chinese
平安证券有限责任公司关于生物工程股份有限公司对募投项目实施方案进行调整的核查意见
Capital/Financing Update Classification · 95% confidence The document is a detailed verification opinion from Ping An Securities regarding adjustments to the implementation plan of a fundraising investment project by Pulike Bioengineering Co., Ltd. It discusses the use and adjustment of funds raised from an IPO, project investment details, approvals, and opinions from independent directors, the supervisory board, and the sponsor institution. The document references regulatory compliance with securities issuance and listing rules, and it is a formal verification report related to the use of raised funds rather than a financial report or earnings announcement. It does not contain financial statements or quarterly/yearly financial results but focuses on the adjustment and verification of fundraising project implementation. This fits the category of a Capital/Financing Update (CAP) as it relates to changes in the use of raised capital and project investment plans.
2016-04-08 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.